# Dabigatran Etexilate

NDC: 67877-624
Generic name: Dabigatran Etexilate
Labeler / Manufacturer: Ascend Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, COATED PELLETS
Routes: ORAL
Marketing started: 20250912

FDA application: ANDA208040

## Active ingredients

- DABIGATRAN ETEXILATE MESYLATE: 110 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67877-624"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67877-624
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a8ec82a-c367-40dc-9302-e1896fcb05ea